Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
140 studies found for:    osteonecrosis
Show Display Options
Rank Status Study
21 Completed Transcription Factor Runx2 in Necrotic Femoral Head Tissue
Condition: Osteonecrosis of Femoral Head
Interventions: Procedure: osteonecrosis of femoral head group;   Procedure: osteoarthritis group
22 Completed Treatment of Osteonecrosis of the Femoral Head by Bone Marrow Transplantation
Condition: Necrosis
Interventions: Procedure: core decompression;   Procedure: Bone marrow implantation into the necrotic lesion
23 Recruiting Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI
Condition: Osteonecrosis
Interventions: Drug: Ferumoxytol-enhanced magnetic resonance imaging;   Device: Magentic Resonance Imaging
24 Enrolling by invitation Autologous Bone Marrow Stem Cell Transplantation for Hip Osteonecrosis in Sickle Cell Disease
Conditions: Avascular Necrosis of Femur Head;   Sickle Cell Disease
Interventions: Procedure: Stem Cell Graft Group;   Biological: Autologous bone marrow stem cell
25 Completed Proposal For The Development Of A Well Defined Database For Patients With Oral Bisphosphonate-Related Osteonecrosis
Condition: Osteonecrosis
Intervention: Other: Observational
26 Recruiting Randomized Clinical Trial for the Treatment of Osteonecrosis of the Femoral Head
Condition: Osteonecrosis
Intervention: Procedure: core decompression
27 Unknown  Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis
Condition: Non-Traumatic Osteonecrosis
Intervention: Drug: Alendronate
28 Completed CONDOR Study of Osteonecrosis of the Jaws (TMJ)
Condition: Osteonecrosis of the Jaw
29 Recruiting Prospective Randomized Study: Assessment of PRF Efficacy in Prevention of Jaw Osteonecrosis After Tooth Extraction
Condition: Bisphosphonate-Associated Osteonecrosis of the Jaw
Interventions: Drug: tooth extraction with antibiotics (amoxicillin- clavulanate, clindamycine);   Procedure: atraumatic extraction
30 Unknown  Hyper Baric Oxygen Therapy (HBOT) for Spontaneous Osteonecrosis of the Knee
Condition: Spontaneous Osteonecrosis of the Knee
Intervention: Biological: Weight reduction
31 Completed Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral Head
Condition: Avascular Necrosis of Femur Head
Interventions: Drug: Core decompression/PREOB® implantation;   Drug: Core decompression/BMC implantation
32 Unknown  Mesenchymal Stem Cell for Osteonecrosis of the Femoral Head
Condition: Osteochondritis of the Femoral Head
Interventions: Biological: mesenchymal stem cell infusion;   Biological: bone marrow mononuclear cell infusion
33 Active, not recruiting Treatment of Medial Compartmental Osteoarthritis Grade 1-4 With TomoFix™ Small or Conservatively
Conditions: Osteoarthritis, Knee;   Osteonecrosis
34 Active, not recruiting S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer;   Lung Cancer;   Metastatic Cancer;   Multiple Myeloma;   Plasma Cell Neoplasm;   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Procedure: assessment of therapy complications
35 Active, not recruiting Osteonecrosis of the Jaw (ONJ) and Infection Among Nordic Cancer Patients Treated With XGEVA™ or Zoledronic Acid
Conditions: ONJ;   Infection
36 Not yet recruiting Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study
Conditions: Osteoporosis;   Osteonecrosis;   Acute Lymphoblastic Leukemia
Intervention: Drug: Zoledronic acid
37 Active, not recruiting Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis
Condition: Osteonecrosis
Interventions: Procedure: Control group;   Biological: Mononuclear Cells;   Biological: Platelets;   Drug: Zoledronic Acid;   Drug: Normal saline
38 Completed Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw
Conditions: Solid Tumours;   Bone Metastasis
Intervention: Other: Physician Survey
39 Recruiting Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use
Conditions: Osteoporosis, With or Without Treatment;   Bisphosphonate Treatment;   Atypical Femur Fracture;   Bisphosphonate Related Osteonecrosis of the Jaws (BRONJ);   Healthy Volunteers
40 Not yet recruiting Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid
Conditions: Malignant Neoplasm;   Musculoskeletal Complications
Interventions: Drug: zoledronic acid;   Other: pharmacological study

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years